NHSWYICB - End of Life Services

2. VI.3.0.1

This is a Provider Selection Regime (PSR) intention to confirmation of contract award notice. The awarding of this This contract is subject to has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to the relevant authority by 27 May 2026. This contract has not yet formally now been awarded; this notice serves as an intention to award a contract under formally awarded using the PSR.Written representations should be sent to wyicb-kirk.procurement@nhs.netThe Direct Award C Process.The assessment was undertaken in accordance with the Provider Selection Regime (PSR) Direct Award Process C, using a structured service review and evaluation methodology.Evaluation of Key CriteriaThe provider was assessed against the five PSR key criteria, using a combination of quantitative performance data, qualitative evidence, and professional judgement:1. Quality and Innovationo Evaluated using performance metrics (e.g. achievement of preferred place of death, patient outcomes), CQC inspection ratings, and service delivery evidence. o Consideration was given to clinical effectiveness, patient experience, safety, innovation, and continuous improvement.o Evidence included activity data, outcome measures, patient feedback, and external assurance (e.g. CQC “Outstanding” domains).2. Valueo Assessed through analysis of contract value against outcomes delivered, including activity levels, avoidance of hospital admissions, and system-wide benefits. o Consideration of cost-effectiveness, benchmarking (where available), and contribution to reducing demand on acute services.3. Integration, Collaboration and Sustainabilityo Evaluated based on the provider’s role within the wider system, including partnership working with NHS, social care, and voluntary sector partners. o Evidence included participation in system forums, joint pathways, and alignment with integrated care objectives.4. Improving Access, Reducing Health Inequalities and Facilitating Choiceo Assessed using evidence of equitable access, responsiveness to population needs, and compliance with equality duties. o Consideration of referral processes, service reach, and support for underserved or vulnerable groups.5. Social Valueo Evaluated based on the provider’s contribution to local communities, including delivery of services locally, workforce impact, and alignment with “Keep it Local” principles.o The evaluation was informed by a multi-disciplinary review, incorporating input from clinical, finance, quality, and commissioning leads. Judgements were based on available evidence and moderated to ensure consistency and objectivity.Evaluation of Basic Selection CriteriaThe basic selection criteria (as set out in PSR guidance) were assessed separately to confirm that the provider:• Meets regulatory requirements, including Care Quality Commission (CQC) registration and compliance• Is technically and professionally capable of delivering the service• Has financial standing and organisational stability appropriate to the contract• Has appropriate governance, safeguarding, and risk management arrangements in placeThis assessment drew on:• Existing contract management intelligence• Regulatory inspection reports (e.g. CQC ratings) • Ongoing performance monitoring and assurance processesDecision-making approach• The assessment combined objective data (performance, activity, outcomes) with qualitative evaluation (confidence in delivery, system fit)• Findings were reviewed and validated through governance processes, including senior management oversight• The outcome reflected whether the provider is meeting current contractual requirements and is likely to continue to do so.